fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
Covid-19

Antibody Levels Remain High Two Months After Receiving the Second Dose of the COVID-19 Vaccine

Antibody
Sheba study indicates only a minor, expected decline in antibody levels among recipients of the Pfizer-BioNTech vaccine

Two months after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, 2,500 of Sheba Medical Center’s employees displayed high blood antibody levels according to a new Sheba study. While a minor decline in blood antibody levels was observed, Prof. Gili Regev-Yochay, Director of the Infectious Diseases Unit at Sheba, says that “this drop was expected, and should not cause alarm.”

Prof. Regev-Yochay added: “We observed blood antibody levels that were much higher than the required threshold in most of the study’s participants. The few participants that displayed a more significant drop are currently being examined to determine whether this drop is indicative of decreased protection against COVID-19 infection.

The initial study on the efficacy of the Pfizer-BioNTech vaccine also included the hospital staff and has shown that the initial results have shown high-level protection against the COVID-19. The study will continue, and participants will be tested again to determine blood antibody levels 3 months after receiving the second vaccine jab.

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More